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General Information.  Commercial reagents were purified prior to use following the 
guidelines of Perrin and Armarego.1 All solvents were purified according to the method 
of Grubbs.2 Organic solutions were concentrated under reduced pressure on a Büchi 
rotary evaporator using an ice-water bath for volatile compounds.  Potassium 
tri(fluoro)borate salts were synthesized from commercially available boronic acids or 
esters using a modified Molander procedure.3  Chromatographic purification of products 
was accomplished using force-flow chromatography on Silicycle silica gel according to 
the method of Still4 and where noted, Iatrobeads 6RS-8060 was used in place of silica 
gel.  Thin-layer chromatography (TLC) was performed on Silicycle 250 µm silica gel 
plates.  Visualization of the developed chromatogram was performed by fluorescence 
quenching and anisaldehyde stain. 
1H and 13C NMR spectra were recorded on a Varian Mercury 300 (300 MHz or 75 
MHz), Mercury 400 (400 MHz or 100 MHz), or an Inova 500 (500MHz and 125 MHz) 
as noted, and are internally referenced to residual protio solvent signals (note: CDCl3 
                                                
(1)  Perrin, D. D.; Armarego, W. L. F. Purification of Laboratory Chemicals; 3rd ed., Pergamon Press, Oxford, 1988. 
(2)  Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics, 1996, 15, 1518. 
(3)  (a) Molander, G. A.; Ito, T. Org. Lett. 2001, 3, 393. (b)  Molander, G. A.; Biolatto, B. Org. Lett.  2002, 4, 1867.  
Note: The cited procedures were found to be more efficient when reaction slurries were sonicated. 
(4)  Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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referenced at δ 7.24).  Data for 1H NMR are reported as follows: chemical shift (δ ppm), 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration, 
coupling constant (Hz) and assignment.  Data for 13C NMR are reported in terms of 
chemical shift.  IR spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer 
and are reported in terms of frequency of absorption (cm-1).  Mass spectra were obtained 
from the California Institute of Technology Mass Spectral Facility and the Princeton 
Mass Spectroscopy Facility.  Gas liquid chromatography (GLC) was performed on 
Hewlett-Packard 6850 and 6890 Series gas chromatographs equipped with split-mode 
capillary injection system and flame ionization detectors using Bodman Chiraldex Γ-TA 
(30 m x 0.25 mm) column.  Supercritical fluid chromatography (SFC) was performed on 
a Berger Minigram equipped with a diode array UV detector (λ = 214–258 nm) using a 
chiral column (25 cm) and guard column (5 cm) as noted for each compound.  
 
General procedure:  To a plastic vial (Wheaton HDPE) is added HF (48 wt%, 
1.0 eq) followed by 1,2-dimethoxyethane (DME) (1M, relative to aldehyde) and a 
magnetic stir bar.  The catalyst and acid co-catalyst are charged to the vial with the 
addition of (2S,5S)-2-tert-butyl-5-((1-benzyl-1H-indol-3-yl)methyl)-3-
methylimidazolidin-4-one (0.2 eq) and HCl (0.2 eq) and is then cooled to temperature (as 
noted).  The reaction is started with the addition of the aldehyde (3.0 eq) to the DME 
solution immediately followed by the addition of the trifluoroborate salt  (1.0 eq).  The 
reaction is stirred at temperature and is often worked-up by an aqueous quench, which is 
then partitioned with dichloromethane, chloroform or ether, as noted.  The combined 
organic layers are dried over Na2SO4 and concentrated in vacuo.  The crude oil is then 
purified by column chromatography (conditions noted) to yield the desired product.  
 
OMe  
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(R, E)-3-methyl-5-phenylpent-4-enal (Table 2, entry 1).  Prepared according to 
the general procedure using crotonaldehyde and potassium trans-styryltrifluoroborate.  
To a plastic vial is added HF (48 wt%, 7.00 mg, 0.167 mmol) followed by DME (500 µL) 
and a magnetic stir bar.  The catalyst and acid co-catalyst are charged to the vial with the 
addition of (2S, 5S)-2-tert-butyl-5-((1-benzyl-1H-indol-3-yl)methyl)-3-
methylimidazolidin-4-one (12.5 mg, 0.033 mmol) and HCl (4N in dioxane, 8.30 µL, 
0.033 mmol) and is then cooled to –20 °C.  Crotonaldehyde (58.0 µL, 0.50 mmol) is 
charged to the DME solution followed by the addition of potassium 2-
benzofuranyltrifluoroborate (37.3 mg, 0.167 mmol).  The reaction is stirred at –20 °C for 
24 hours and quenched with 1M HCl (1.0 mL) and is stirred with chloroform (1.5 mL) 
for 30 minutes.  The organic layer is extracted with CH2Cl2 (2 x 2.0 mL), dried over 
Na2SO4, filtered through celite (ether wash) and concentrated in vacuo.  Purification by 
chromatography (silica gel, 20% ether in pentanes) yields the title compound as clear oil 
(27.9 mg, 96% yield, 87% ee).  IR (film) 2962, 1718, 965.0, 747.0, 692.5 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 9.76 (t, 1H, J = 2.1 Hz, CHO), 7.34-7.19 (m, 5H, aryl H), 6.42 (dd, 
1H, J = 0.6, 15.9 Hz, CH=CH), 6.14 (dd, 1H, J = 7.5, 15.9 Hz, CH=CH), 2.94 (m, 1H, 
CHCH3), 2.50 (ddd, 2H, J = 2.1, 6.9, 16.5 Hz, CH2), 1.16 (d, 3H, CH3); 13C NMR (75 
MHz, CDCl3) δ 202.33, 134.16, 129.32, 128.76, 127.50, 126.33, 50.60, 32.08, 20.65; 
HRMS (EI+) exact mass calculated for [M]+• (C12H14O) requires m/z 174.1045, found m/z 
174.1051; [α]D= –49.1 (c = 0.45, CHCl3). The enantiomeric excess was determined on 
the alcohol product, which was prepared by a NaBH4 reduction, by SFC analysis using a 
Chiralcel OD-H column (5% to 35% IPA, linear gradient, 100 bar, 35 °C oven, flow = 
4.0 mL/min); (S) isomer tr = 4.75 min, (R) isomer tr = 5.35 min. 
 
 Determination of the absolute stereochemistry of (R,E)-3-methyl-5-
phenylpent-4-enal by correlation to methyl [1-((E)-sytryl)ethyl]acetate.5  Aldehyde 4 
                                                
(5)  Hayashi, T.; Yamamoto, A.; Hagihara, T. J. Org. Chem. 1986, 51, 723 (reported [α]D= –49.2 (c = 1.3, CCl4) for a 
product that was 79% ee). 
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(22.0 mg, 0.126 mmol) was subjected to oxidation6 using Oxone® (77.6 mg, 0.126 
mmol) in DMF (1.26 mL) to quantitatively produce the corresponding acid (24.0 mg, 
0.126 mmol).  Subsequently, the acid was esterified using TMS diazomethane (2M in 
hexane, 130 µL) in a solution of 25% methanol in benzene (1.0 mL) at room temperature.  
Purification was accomplished via chromatography (prep TLC, 20% ether in pentanes) to 
yield (R, E)-methyl 3-methyl-5-phenylpent-4-enoate in 34% isolated yield.  1H NMR and 
13C NMR (500 MHz, CCl4 with TMS internal reference) spectral data matched literature 
values.4  1H NMR (400 MHz, CDCl3) δ 7.34-7.18 (m, 5H, aryl H), 6.38 (d, 1H, J = 15.6 
Hz, CH=CH), 6.12 (dd, 1H, J = 7.6, 15.9 Hz, CH=CH), 6.14 (dd, 1H, J = 7.5, 16.0 Hz, 
CH=CH), 3.65 (s, 3H, OCH3), 2.84 (septet, 1H, J = 7.2 Hz, CHCH2), 2.39 (ddd, 2H, J = 
7.2, 14.4, 21.6 Hz, CH2) 1.13 (d, 3H, J = 6.4 Hz, CH3); 13C NMR (100 MHz, CDCl3) δ 
173.1, 134.4, 129.1, 128.7, 127.4, 126.3, 51.74, 41.73, 34.22, 20.42; [α]D= –57.8 (c = 
0.502, CCl4). 
 
OMe
OMe
 
(R,E)-5-(4-methoxyphenyl)-3-methylpent-4-enal (Table 2, entry 2).  Prepared 
according to the general procedure using crotonaldehyde and potassium trans-2-(4-
methoxyphenyl)trifluoroborate.  To a plastic vial is added HF (48 wt%, 3.5 mg, 0.083 
mmol) followed by DME (250 µL) and a magnetic stir bar.  The catalyst and acid co-
catalyst are charged to the vial with the addition of (2S, 5S)-2-tert-butyl-5-((1-benzyl-1H-
indol-3-yl)methyl)-3-methylimidazolidin-4-one (6.25 mg, 0.017 mmol) and HCl (4N in 
dioxane, 4.2 µL, 0.017 mmol) and is then cooled to –40 °C.  Crotonaldehyde (21.0 µL, 
0.25 mmol) is charged to the DME solution followed by the addition of potassium trans-
2-(4-methoxyphenyl)trifluoroborate (20.0 mg, 0.083 mmol).  The reaction is stirred at –
                                                
(6) Travis, B. R.; Sivakumar, M.; Hollist, G. O.; Borhan, B. Org. Lett. 2003, 5, 1031. 
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40 °C for 20 hours and quenched with 1M HCl (1.0 mL) and is stirred with chloroform 
(1.5 mL) for 30 minutes.  The organic layer is extracted with CH2Cl2 (2 x 2.0 mL), dried 
over Na2SO4, filtered through celite (ether wash) and concentrated in vacuo.  Purification 
by chromatography (prep TLC, 10% ether in pentanes) yields the title compound as clear 
oil (13.9 mg, 70% yield, 88% ee).  IR (film) 2954, 1720, 1605, 1510, 1243, 1174, 1030, 
964.8, 804.7 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.77 (t, 1H, J = 2.1 Hz, CHO), 7.27 (d, 
2H, J = 8.4 Hz, aryl H), 6.84 (d, 2H, J = 9.0 Hz, aryl H), 6.36 (d, 1H, J = 15.9 Hz, 
CH=CH), 6.01 (dd, 1H, J = 7.5, 15.9 Hz, CH=CH), 3.80 (s, 3H, OCH3), 2.93 (m, 1H, 
CHCH2), 2.50 (ddd, 2H, J = 2.1, 7.2, 16.2 Hz, CH2), 1.17 (d, 3H, J = 6.6 Hz, CH3); 13C 
NMR (75 MHz, CDCl3) δ 202.54, 159.17, 132.01, 130.11, 128.68, 127.44, 114.15, 55.51, 
50.73, 32.11, 20.79; HRMS (EI+) exact mass calculated for [M]+• (C13H16O2) requires m/z 
204.1150, found m/z 204.1150; [α]D= –44.0 (c = 1.26, CHCl3).  The enantiomeric excess 
was determined by SFC analysis using a Chiralpak AS-H column (5% to 10% MeCN, 
linear gradient, 100 bar, 35 °C oven, flow = 4.0 mL/min); (S) isomer tr = 4.03 min, (R) 
isomer tr = 4.68 min. 
 
OMe
Ph
 
(R,E)-5-(4-biphenyl)-3-methylpent-4-enal (Table 2, entry 3). Prepared 
according to the general procedure using crotonaldehyde and potassium trans-2-
(biphenyl)trifluoroborate.  To a plastic vial is added HF (48 wt%, 6.3 mg, 0.15 mmol) 
followed by DME (450 µL) and a magnetic stir bar.  The catalyst and acid co-catalyst are 
charged to the vial with the addition of (2S, 5S)-2-tert-butyl-5-((1-benzyl-1H-indol-3-
yl)methyl)-3-methylimidazolidin-4-one (11.3 mg, 0.03 mmol) and HCl (4N in dioxane, 
7.5 µL, 0.03 mmol) and is then cooled to –40 °C.  Crotonaldehyde (37.5 µL, 0.45 mmol) 
is charged to the DME solution followed by the addition of potassium trans-2-(4-
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biphenyl)trifluoroborate (42.9 mg, 0.15 mmol).  The reaction is stirred at –40 °C for 24 
hours and was directly subjected to purification by chromatography (Iatrobeads, 1% 
acetone and 5% ether in pentanes) to yield the title compound as light, yellow solid (20.6 
mg, 91% yield, 95% ee).  IR (film) 2924, 2854, 1724, 972.3, 761.7, 694.4 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 9.78 (t, 1H, J = 2.0 Hz, CHO), 7.58-7.52 (m, 4H, aryl H), 7.43-7.39 
(m, 4H, aryl H), 7.33-7.24 (m, 1H, aryl H), 6.44 (d, 1H, J = 16.0 Hz, CH=CH), 6.19 (dd, 
1H, J = 7.5, 16.0 Hz, CH=CH), 2.97 (septet, 2H, J = 7.0 Hz, CHCH2), 2.52 (ddd, 2H, J = 
2.0, 7.0, 16.5 Hz, CH2), 1.18 (d, 3H, J = 7.0 Hz, CH3); 13C NMR (125 MHz, CDCl3) δ 
202.21, 140.95, 140.31, 136.41, 134.34, 128.99, 128.93, 127.46, 127.12, 126.77, 50.65, 
32.15, 29.92, 20.67; HRMS (EI+) exact mass calculated for [M]+• (C13H16O2) requires m/z 
250.1358, found m/z 250.1349; [α]D= –13.6 (c = 1.29, CHCl3).  The enantiomeric excess 
was determined by SFC analysis using a Chiralcel OJ-H column (5% to 15% MeCN, 
2%/min gradient, 100 bar, 35 °C oven, flow = 4.0 mL/min); (S) isomer tr = 2.97 min, (R) 
isomer tr = 3.23 min. 
 
OMe
O
O
 
5-((R)-1-formylpropan-2-yl)furan-2-carbaldehyde (Table 2, entry 4).  
Prepared according to the general procedure using crotonaldehyde and potassium 2-(5-
formylfuran-2-yl) trifluoroborate.  To a plastic vial is added HF (48 wt%, 3.5 mg, 0.083 
mmol) followed by DME (250 µL) and a magnetic stir bar.  The catalyst and acid co-
catalyst are charged to the vial with the addition of (2S, 5S)-2-tert-butyl-5-((1-benzyl-1H-
indol-3-yl)methyl)-3-methylimidazolidin-4-one (6.25 mg, 0.017 mmol) and HCl (4N in 
dioxane, 4.2 µL, 0.017 mmol) and is then cooled to –20 °C.  Crotonaldehyde (21.0 µL, 
0.25 mmol) is charged to the DME solution followed by the addition of potassium 2-(5-
formylfuran-2-yl) trifluoroborate (20.0 mg, 0.083 mmol).  The reaction is stirred at –20 
°C for 20 hours and quenched with 1M HCl (1.0 mL) and is stirred with ether (1.5 mL) 
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for 30 minutes.  The organic layer is extracted with ether (2 x 2.0 mL), dried over 
Na2SO4, filtered through celite (ether wash) and concentrated in vacuo (ice-water bath).  
Purification by chromatography (silica gel, 10% ether in pentanes) yields the title 
compound as a clear, light yellow oil (11.7 mg, 85% yield, 95% ee).  IR (film) 1719, 
1670, 1513, 1020 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.75 (t, 1H, J = 1.5 Hz, CHO), 
9.51 (s, 1H, furyl CHO), 7.17 (d, 1H, J = 3.6 Hz, aryl H), 6.30 (dd, 1H, J = 0.9, 3.6, aryl 
H), 3.53 (m, 1H, CHCH3), 2.81 (ddd, 2H, J = 1.5, 7.2, 17.7 Hz, CH2), 1.35 (d, 3H, J = 7.2 
Hz, CH3); 13C NMR (75 MHz, CDCl3) δ 200.53, 177.45, 152.56, 123.72, 108.38, 49.08, 
28.55, 19.07; HRMS (EI+) exact mass calculated for [M+•] (C9H10O3) requires m/z 
166.0630, found m/z 166.0629; [α]D= –1.09 (c = 1.17, CHCl3).  The enantiomeric excess 
was determined by SFC analysis using a Chiralpak AS-H column (5% to 10% MeCN, 
linear gradient, 100 bar, 35 °C oven, flow = 4.0 mL/min); (S) isomer tr = 2.73 min, (R) 
isomer tr = 3.63 min. 
 
OMe
O
 
(R)-3-(benzofuran-2-yl)butanal (Table 2, entry 5).  Prepared according to the 
general procedure using crotonaldehyde and potassium 2-benzofuranyltrifluoroborate.7  
To a plastic vial is added HF (48 wt%, 6.25 mg, 0.167 mmol) followed by DME (450 µL) 
and a magnetic stir bar.  The catalyst and acid co-catalyst are charged to the vial with the 
addition of (2S, 5S)-2-tert-butyl-5-((1-benzyl-1H-indol-3-yl)methyl)-3-
methylimidazolidin-4-one (11.3 mg, 0.033 mmol) and HCl (4N in dioxane, 7.50 µL, 
0.033 mmol) and is then cooled to –20 °C.  Crotonaldehyde (37.3 µL, 0.45 mmol) is 
charged to the DME solution followed by the addition of potassium 2-
benzofuranyltrifluoroborate (33.6 mg, 0.150 mmol).  The reaction is stirred at –20 °C for 
                                                
(7) Murphy, J. M.; Tzschucke, C. C.; Hartwig, J. F. Org. Lett. 2007, 9, 757. 
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23 hours and then flushed though a silica gel plug (wash with 30% ether in pentanes).  
Concentration in vacuo (ice-water bath) provided the title compound as clear oil (25.5 
mg, 90% yield, 97% ee).  IR (film) 1722, 1454, 1253, 1168, 750.6 cm-1; 1H NMR (300 
MHz, CDCl3) δ 9.84 (s, 1H, CHO), 7.54-7.43 (m, 2H, aryl H), 7.29-7.19 (m, 2H, aryl H), 
6.45 (t, 1H, J = 0.9 Hz, 3'-benzofuran H), 3.61 (m, 1H, CHCH3), 2.85 (dd, 2H, J = 1.80, 
17.1 Hz, CH2), 1.45 (d, 3H, J = 6.60 Hz, CH3); 13C NMR (75 MHz, CDCl3) δ 201.06, 
161.47, 154.81, 128.68, 123.81, 122.81, 120.75, 111.07, 101.58, 49.06, 28.38, 19.04; 
HRMS (EI+) exact mass calculated for [M]+• (C12H12O2) requires m/z 188.0837, found m/z 
188.0844; [α]D= –17.1 (c = 1.22, CHCl3).  The enantiomeric excess was determined on 
the alcohol product, which was prepared by a NaBH4 reduction, by SFC analysis using a 
Chiralpak AS-H column (5% to 50% MeOH, linear gradient, 100 bar, 35 °C oven, flow = 
4.0 mL/min); (S) isomer tr = 2.17 min, (R) isomer tr = 2.40 min. 
 
OMe
O
MeO
 
(R)-3-(5-methoxybenzofuran-2-yl)butanal (Table 2, entry 6).  Prepared 
according to the general procedure using crotonaldehyde and potassium 2-(5-
methoxybenzofuranly)trifluoroborate.  To a plastic vial is added HF (48 wt%, 6.25 mg, 
0.15 mmol) followed by DME (450 µL) and a magnetic stir bar.  The catalyst and acid 
co-catalyst are charged to the vial with the addition of (2S, 5S)-2-tert-butyl-5-((1-benzyl-
1H-indol-3-yl)methyl)-3-methylimidazolidin-4-one (10.9 mg, 0.03 mmol) and HCl (4N 
in dioxane, 7.5 µL, 0.03 mmol) and is then cooled to –20 °C.  Crotonaldehyde (37.5 µL, 
0.45 mmol) is charged to the DME solution followed by the addition of potassium 2-(5-
methoxybenzofuranyl)trifluoroborate (42.4 mg, 0.15 mmol).  The reaction is stirred at –
20 °C for 24 hours and quenched with 1M HCl (1.0 mL) and is stirred with chloroform 
(1.5 mL) for 30 minutes.  The organic layer is extracted with chloroform (2 x 2.0 mL), 
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dried over Na2SO4, filtered through celite (ether wash) and concentrated in vacuo.  
Purification by chromatography (silica gel, 15% ether in pentanes) yields the title 
compound as clear oil (30.7 mg, 94% yield, 92% ee).  IR (film) 1724, 1475, 1205, 1030 
cm-1;  1H NMR (300 MHz, CD2Cl2) δ 9.78 (t, 1H, J = 1.5 Hz, CHO), 7.29 (d, 1H, J = 8.4 
Hz, aryl H), 6.98 (d, 1H, J = 2.4 Hz, aryl H), 6.81 (dd, 1H, J = 2.4, 9.0 Hz,  aryl H), 6.38 
(d, 1H, J = 0.9 Hz), 3.01 (s, 3H, OCH3), 3.54 (m, 1H, CHCH3), 2.79 (ddd, 2H, J = 1.5, 
6.6, 17.4 Hz, CH2), 1.39 (d, 3H, J = 0.9 Hz, CH3);  13C NMR (75 MHz, CDCl3) δ 201.32, 
163.07, 156.46, 150.05, 129.72, 112.37, 111.60, 103.72, 101.93, 56.29, 49.30, 28.78, 
19.18;  HRMS (EI+) exact mass calculated for [M]+• (C13H14O3) requires m/z 218.0943, 
found m/z 218.0944; [α]D= –8.51 (c = 1.29, CHCl3).  The enantiomeric excess was 
determined by SFC using a Chiracel OJ-H column (5% to 10% MeCN, linear gradient, 
100 bar, 35 °C oven, flow = 4.0 mL/min); (S) isomer tr = 5.17 min, (R) isomer tr = 5.61 
min.                      
 
Determination of the absolute stereochemistry of (R)-3-(5-
methoxybenzofuran-2-yl)butanal by correlation to (R)-3-(5-methoxybenzofuran-2-
yl)butan-1-ol.8  To a stirring solution of the aldehyde (25 mg, 0.11 mmol) in CH2Cl2(2.0 
mL) and ethanol (20 µL) at 0 °C was added NaBH4 (13 mg, 0.34 mmol).  The reaction 
was quenched after 5 minutes by a saturated solution of Rochelle’s salt  (2.0 mL).  The 
organic was extracted with ether (2 x 3.0 mL) and concentrated in vacuo to yield a clear 
oil (quantitative yield) with spectroscopic data matching literature values. IR (film) 3306 
(br), 2922, 1458, 1201, 1026 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.28 (d, 1H, J = 8.7 Hz, 
aryl H), 6.94 (d, 1H, J = 2.7 Hz, aryl H), 6.79 (dd, 1H, J = 2.7, 8.7 Hz, aryl H), 6.33 (s, 
1H, aryl H), 3.81 (s, 3H, OCH3), 3.69 (m, 2H, CH2CH2), 3.11 (m, 1H, CHCH3), 2.06-
1.95 (m, 1H, CH2OH), 1.91-1.79 (m, 1H, CH2OH), 1.57 (br s, 1H, OH), 1.34 (d, 3H, J = 
7.2 Hz, CH3); 13C NMR (75 MHz, CDCl3) δ 164.11, 155.98, 149.73, 129.48, 111.81, 
111.38, 103.45, 101.40, 60.97, 56.16, 38.53, 30.56, 19.38; HRMS (EI+) exact mass 
                                                
(8)  Hughes, C. C.; Trauner, D. Tetrahedron, 2004, 60, 9675 (reported [α]D= –33.0 (c = 1.00, CHCl3) for a product that 
was 91% ee).  
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calculated for [M+1] (C13H16O3) requires m/z 220.1100, found m/z 220.1089; [α]D= –46.2 
(c = 0.83, CHCl3).6  The enantiomeric excess was determined by SFC analysis using a 
Chiralcel OJ-H column (5% to 10% methanol, linear gradient, 100 bar, 35 °C oven, flow 
= 4.0 mL/min); (S) isomer tr = 5.71 min, (R) isomer tr = 6.56 min. 
 
Determination of the absolute stereochemistry of (R)-3-(5-
methoxybenzofuran-2-yl)butanal by obtaining a crystal structure of  (R)-3-(5-
methoxybenzofuran-2-yl)butyl 4-bromobenzoate (vide S 17).  Esterification of (R)-3-
(5-methoxybenzofuran-2-yl)butan-1-ol (22 mg, 0.10 mmol) proceeded in a solution of 
CH2Cl2 (1.0 mL) to which NEt3 (21 µL, 0.15 mmol) and DMAP (1.2 mg, 0.01 mmol) 
were added.  The solution was then cooled to 0 °C and p-Br benzoyl chloride (24 mg, 
0.11 mmol) was added.  The ice bath was removed and after 30 minutes at room 
temperature, 0.5 M HCl (2.0 mL) was added to quench the reaction.  The organic layer 
was dried with Na2SO4, triturated diethyl ether, filtered (to remove salt impurities) and 
concentrated in vacuo to yield a yellow solid (34 mg, 85% yield).  IR (film) 2929, 1719, 
1591, 1477, 1271, 1205, 1102, 1012, 756.3 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.74 (d, 
2H, J = 8.4 Hz, aryl H), 7.47 (d, 2H, J = 8.4 Hz, aryl H), 7.22 (s, 1H, aryl H), 6.89 (d, 
1H, J = 2.8 Hz, aryl H), 6.77 (dd, 1H, J = 2.8, 9.2 Hz, aryl H), 6.32 (s, 1H,  aryl H), 4.33 
(m, 2H, CH2OC(O)), 3.78 (s, 3H, OCH3), 3.11 (m, 1H, CH3CH), 2.25-2.01 (m, 2H, CH2), 
1.37 (t, 3H, J = 7.2 Hz, CHCH3); 13C NMR (100 MHz, CDCl3) δ 165.95, 163.18, 155.97, 
149.75, 131.76, 131.17, 129.40, 129.18, 128.11, 111.85, 111.32, 103.42, 101.62, 63.41, 
56.10, 34.32m 31.20, 19.23; HRMS (EI+) exact mass calculated for [M+•] (C20H19O4Br) 
requires m/z 402.0467, found m/z 402.0481; [α]D= –52.7 (c = 1.02, CHCl3). 
 
OMe
N
BOC
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tert-butyl 2-((R)-1-formylpropan-2-yl)-1H-indole-1-carboxylate (Table 2, 
entry 7).  Prepared according to the general procedure using crotonaldehyde and 
potassium 2-(tert-butyl 1H-indole-1-carboxylate)trifluoroborate.  To a plastic vial is 
added HF (48 wt%, 3.5 mg, 0.083 mmol) followed by DME (250 µL) and a magnetic stir 
bar.  The catalyst and acid co-catalyst are charged to the vial with the addition of (2S,5S)-
2-tert-butyl-5-((1-benzyl-1H-indol-3-yl)methyl)-3-methylimidazolidin-4-one (12.4 mg, 
0.033 mmol) and HCl (4N in dioxane, 8.3 µL, 0.033 mmol) and is then cooled to –20 °C.  
Crotonaldehyde (21.0 µL, 0.25 mmol) is charged to the DME solution followed by the 
addition of potassium 2-(tert-butyl 1H-indole-1-carboxylate)trifluoroborate (26.9 mg, 
0.083 mmol).  The reaction is stirred at –20 °C for 24 hours and quenched with 1M HCl 
(1.0 mL) and is stirred with chloroform (1.5 mL) for 30 minutes.  The organic layer is 
extracted with chloroform (2 x 2.0 mL), dried over Na2SO4, filtered through celite (ether 
wash) and concentrated in vacuo.  Purification by chromatography (silica gel, 10% ether 
in pentanes) yields the title compound as light yellow oil (19.0 mg, 79% yield, 91% ee).  
IR (film) 1728, 1455, 1370, 1327, 1157, 747.4 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.77 
(t, 1H, J = 1.8 Hz, CHO), 8.03 (dt, 1H, J = 0.6, 7.8 Hz, aryl H), 7.45 (m, 1H, aryl H), 
7.26-7.15 (m, 2H, aryl H), 6.40 (t, 1H, J = 0.9, aryl H), 4.24 (m, 1H, CHCH3), 2.57 (dd, 
1H, CH2), 2.89 (1H, dd, J = 1.8, 5.4 Hz, CH2), 1.37 (t, 3H, J = 6.9 Hz, CH3); 13C NMR 
(75 MHz, CDCl3) δ 201.95, 150.69, 145.80, 129.22, 123.96, 123.00, 120.28, 115.94, 
106.42, 84.47, 50.80, 28.45, 28.02, 21.06; HRMS (EI+) exact mass calculated for [M+•] 
(C17H21NO3) requires m/z 287.1521, found m/z 287.1533; [α]D= –6.1 (c = 0.6, CHCl3).  
The enantiomeric excess was determined by SFC analysis using a Chiralcel OD-H 
column (5% to 50% MeCN, linear gradient, 100 bar, 35 °C oven, flow = 4.0 mL/min); (S) 
isomer tr = 2.51 min, (R) isomer tr = 2.97 min. 
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(R)-3-(benzofuran-2-yl) hexanal (Table 3, entry 2).  Prepared according to the 
general procedure using hexenal and potassium 2-benzofuranyltrifluoroborate.  To a 
plastic vial is added HF (48 wt%, 7.00 mg, 0.167 mmol) followed by DME (500 µL) and 
a magnetic stir bar.  The catalyst and acid co-catalyst are charged to the vial with the 
addition of (2S, 5S)-2-tert-butyl-5-((1-benzyl-1H-indol-3-yl)methyl)-3-
methylimidazolidin-4-one (12.5 mg, 0.033 mmol) and HCl (4N in dioxane, 8.30 µL, 
0.033 mmol) and is then cooled to 4 °C.  Hexenal (58.0 µL, 0.50 mmol) is charged to the 
DME solution followed by the addition of potassium 2-benzofuranyltrifluoroborate (37.3 
mg, 0.167 mmol).  The reaction is stirred at 4 °C for 12 hours and quenched with a 
saturated solution of Rochelle’s salt (1.0 mL) and is partitioned with dichloromethane (2 
x 1.5 mL).  The combined organic layers are dried over Na2SO4, concentrated in vacuo 
and purified by chromatography (silica gel, 10% ether in pentanes) to yield the title 
compound as clear oil (34.9 mg, 97% yield, 93% ee).  IR (film) 2959, 2932, 2873, 1725, 
1456, 1253, 751.8 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.75 (s, 1H, CHO), 7.49-7.38 (m, 
2H, aryl H), 7.24-7.14 (m, 2H, aryl H), 6.42 (s, 1H, 3'-benzofuran H), 3.48-3.39 (m, 1H, 
CH2CHCH2), 2.80 (ddd, 2H, J = 1.8, 7.5, 17.1 Hz, α-CH2), 1.85-1.58 (m, 2H, CH2), 1.37-
1.24 (m, 2H, CH2), 0.89 (t, 3H, J = 6.9 Hz, CH3); 13C NMR (125 MHz, CDCl3) δ 201.31, 
147.98, 132.55, 123.73, 122.82, 120.73, 111.12, 102.85, 67.13, 47.70, 35.97, 33.69, 
20.48, 14.07; HRMS (EI+) exact mass calculated for [M]+• (C14H16O2) requires m/z 
216.1150, found m/z 216.1142; [α]D= –7.3 (c = 1.05, CHCl3).  The enantiomeric excess 
was determined on the alcohol product, which was prepared by a NaBH4 reduction, and 
analyzed by SFC using a Chiralpak AS-H column (5% to 25% IPA, linear gradient, 100 
bar, 35 °C oven, flow = 4.0 mL/min); (S) isomer tr = 3.18 min, (R) isomer tr = 3.36 min. 
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(R)-methyl 2-(benzofuran-2-yl)-3-formylpropanoate (Table 3, entry 3).  
Prepared according to the general procedure using (E)-methyl 3-formylacrylate and 
potassium 2-benzofuranyltrifluoroborate.  To a plastic vial is added HF (48 wt%, 7.00 
mg, 0.167 mmol) followed by DME (500 µL) and a magnetic stir bar.  The catalyst and 
acid co-catalyst are charged to the vial with the addition of (2S, 5S)-2-tert-butyl-5-((1-
benzyl-1H-indol-3-yl)methyl)-3-methylimidazolidin-4-one (12.5 mg, 0.033 mmol) and 
HCl (4N in dioxane, 8.30 µL, 0.033 mmol) and is then cooled to –20 °C.  (E)-Methyl 3-
formylacrylate (58.0 µL, 0.50 mmol) is charged to the DME solution followed by the 
addition of potassium 2-benzofuranyltrifluoroborate (37.3 mg, 0.167 mmol).  The 
reaction is stirred at –20 °C for 18 hours and quenched with 1M HCl (1.0 mL) and is 
stirred in chloroform (1.5 mL) for 30 minutes.  The organic layer is extracted with 
chloroform (2 x 2.0 mL), dried over Na2SO4, concentrated in vacuo and purified by 
chromatography (silica gel, 25% ether in pentanes) to yield the title compound as clear 
oil (36.0 mg, 93% yield, 88% ee).  IR (film) 1736, 1720, 1453, 1168, 750.9 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 9.82 (s, 1H, CHO), 7.52-7.40 (m, 2H, aryl H), 7.28-7.17 (m, 
2H, aryl H), 6.58 (s, 1H, 3'-benzofuran H), 4.42 (dd, 1H, J = 5.1, 9.0 Hz, CHCH2), 3.73 
(s, 3H, OCH3), 3.45 (ddd, 1H, J = 0.6, 9.0, 18.6 Hz, CH2), 3.02 (ddd, 1H, J = 0.6, 5.1, 
18.6 Hz, CH2); 13C NMR (75 MHz, CDCl3) δ 198.82, 191.57, 147.97, 132.45, 128.33, 
124.52, 123.18, 121.14, 111.42, 104.62, 53.120, 44.37, 39.39; HRMS (EI+) exact mass 
calculated for [M]+• (C13H12O4) requires m/z 232.0736, found m/z 232.0728; [α]D= –95.0 
(c = 0.8, CHCl3).  The enantiomeric excess was determined on the diol product, which is 
prepared by reduction of the ester and aldehyde (21.5 mg, 0.093 mmol) in THF (1mL) 
using LiAlH4 (1M in THF, 200 µL, 0.2 mmol) at –60 °C.  SFC analysis was performed 
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using a Chiralpak AD-H column (5% to 15% methanol, linear gradient, 100 bar, 35 °C 
oven, flow = 4.0 mL/min); (S) isomer tr = 10.23 min, (R) isomer tr = 10.80 min. 
 
O
O
O2N  
(S)-3-(Benzofuran-2-yl)-3-(4-nitrophenyl)propanal (Table 3, entry 5).  
Prepared according to the general procedure using p-nitrocinnamaldehyde and potassium 
2-benzofuranyltrifluoroborate.  To a plastic vial is added HF (48 wt%, 3.50 mg, 0.083 
mmol) followed by DME (250 µL) and a magnetic stir bar.  The catalyst and acid co-
catalyst are charged to the vial with the addition of (2S, 5S)-2-tert-butyl-5-((1-benzyl-1H-
indol-3-yl)methyl)-3-methylimidazolidin-4-one (6.26 mg, 0.017 mmol) and HCl (4N in 
dioxane, 4.20 µL, 0.017 mmol).  p-Nitrocinnamaldehye (44.3 mg, 0.250 mmol) is 
charged to the DME solution followed by the addition of potassium 2-
benzofuranyltrifluoroborate (18.7 mg, 0.083 mmol).  The reaction is stirred at ambient 
temperature for 24 hours and quenched with a saturated solution of Rochelle’s salt (1.0 
mL) and is then partitioned with dichloromethane (2 x 1.5 mL).  The combined organic 
layers are dried over Na2SO4, concentrated in vacuo and purified by chromatography 
(prep TLC, 25% dichloromethane in benzene) to yield the title compound as a light 
yellow oil (16.9 mg, 69% yield, 92% ee).  IR (film) 1724, 1519, 1454, 1347, 1254, 752.1 
cm-1; 1H NMR (300 MHz, CDCl3) δ 9.81 (s, 1H, CHO), 8.19 (d, 2H, J = 8.4 Hz, aryl H), 
7.53-7.39 (m, 4H, aryl H), 7.28-7.18 (m, 2H, aryl H), 6.50 (s, 1H, 3'-benzofuran H), 4.90 
(t, 1H, J = 7.2 Hz, CH2CH), 3.32 (dd, 2H, J = 6.9, 17.7 Hz, CH2); 13C NMR (125 MHz, 
CDCl3) δ 198.65, 157.20, 147.99, 129.13, 124.55, 124.30, 123.25, 121.11, 111.32, 
104.11, 47.82, 39.16; HRMS (EI+) exact mass calculated for [M]+• (C17H13NO4) requires 
m/z 295.0845, found m/z 295.0853; [α]D= 48.7 (c = 1.0, CHCl3).  The enantiomeric 
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excess was determined on the alcohol product, which was prepared by a NaBH4 
reduction, and analyzed by SFC using a Chiralpak AS-H column (5% to 25% methanol, 
linear gradient, 100 bar, 35 °C oven, flow = 4.0 mL/min); (S) isomer tr = 6.93 min, (R) 
isomer tr = 7.22 min. 
 
O
O
O
O
O2N
 
(S)-2-(benzofuran-2-yl)-3-formylpropyl 4-nitrobenzoate (Table 3, entry 4). 
Prepared according to the general procedure using (E)-3-formylallyl 4-nitrobenzoate and 
potassium 2-benzofuranyltrifluoroborate.  To a plastic vial is added HF (48 wt%, 2.1 mg, 
0.05 mmol) followed by DME (150 µL) and a magnetic stir bar.  The catalyst and acid 
co-catalyst are charged to the vial with the addition of (2S,5S)-2-tert-butyl-5-((1-benzyl-
1H-indol-3-yl)methyl)-3-methylimidazolidin-4-one (7.51 mg, 0.02 mmol) and HCl (4N 
in dioxane, 5.0 µL, 0.02 mmol).  (E)-3-Formylallyl 4-nitrobenzoate (35.3 mg, 0.15 
mmol) is charged to the DME solution followed by the addition of potassium 2-
benzofuranyltrifluoroborate (11.2 mg, 0.05 mmol).  The reaction is stirred at –20 °C for 
23 hours and quenched with 1M HCl (1.0 mL) and is stirred with chloroform (1.5 mL) 
for 30 minutes.  The organic layer is extracted with chloroform (2 x 2.0 mL), dried over 
Na2SO4, concentrated in vacuo and purified by chromatography (prep TLC, 40% 
dichloromethane in benzene) to yield the title compound as a yellow oil (13.3 mg, 75% 
yield, 89% ee).  IR (film) 1725, 1526, 1348, 1272, 1120, 1103, 752.6, 718.2 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 9.84 (t, 1H, J = 1.2 Hz, CHO), 8.19 (dd, 4H, J = 2.1, 39.9 Hz, 
aryl H), 7.45 (dd, 2H, J = 7.5, 27.6 Hz, aryl H), 7.28-7.17 (m, 2H, aryl H), 6.57 (s, 1H, 
3'-benzofuran H), 4.66 (dd, 2H, J = 6.3, 10.8 Hz, CH2OBz), 4.07-3.98 (m, 1H, CHCH2), 
3.04 (ddd, 2H, J = 1.2, 6.6, 18.0 Hz, CHCH2); 13C NMR (75 MHz, CDCl3) δ 199.20, 
164.53, 156.03, 135.21, 130.98, 128.29, 124.44, 123.85 121.08, 111.25, 104.05, 66.47, 
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44.23, 33.31; HRMS (EI+) exact mass calculated for [M]+• (C19H15NO6) requires m/z 
353.0899, found m/z 353.0885; [α]D= +6.29 (c = 1.06, CHCl3).  The enantiomeric excess 
was determined on the alcohol product, which was prepared by a NaBH4 reduction, and 
analyzed by SFC using a Chiralpak AD-H column (30% to 50% methanol, linear 
gradient, 100 bar, 35 °C oven, flow = 4.0 mL/min); (S) isomer tr = 5.78 min, (R) isomer tr 
= 6.34 min. 
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Crystal Structure Analysis of: 
4-Bromobenzoic Acid (R)-3-(5-Methoxybenzofuran-2-yl)butyl Ester (DWCM003) 
 
For Investigator: Sandra Lee    
 Advisor: David W. C. MacMillan   
By Douglas M. Ho 
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Computer programs 
 
4-Bromobenzoic Acid (R)-3-(5-Methoxybenzofuran-2-yl)butyl Ester (DWCM003) 
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Experimental 
 
Evaporation of a carbon disulfide solution of the compound yielded a yellow oil.  
Upon standing at room temperature for a number of hours, the oil crystallized into 
colorless bundles of intergrown plates.  A fragment approximately 0.03 mm x 0.08 mm x 
0.25 mm in size was cut from one of the plates, mounted on a glass fiber with silicone 
grease and transferred to a Nonius KappaCCD diffractometer equipped with an MSC X-
stream cryosystem and Mo Kα radiation (λ = 0.71073 Å).  Fourteen hundred and forty 
frames of data were collected at 200(2) K with an ω oscillation range of 0.5°/frame, and 
an exposure time of 60 s/deg.9  A total of 7927 reflections (θmax = 22.46°) were indexed, 
integrated and corrected for Lorentz and polarization effects using DENZO-SMN and 
SCALEPACK.10  The crystal did not exhibit any usable data beyond that θmax value.  
Therefore, a standard 0.76961 Å (θmax = 27.5°) data set was not warranted or pursued.  
Gaussian and ψ-scan absorption corrected data sets were also examined but did not lead 
to improved refinement results and were therefore not pursued further as well.  Data 
reduction yielded 2296 unique reflections (Rint = 0.066) of which 1735 had I > 2σ(I). 
Postrefinement of the unit cell parameters gave a = 5.8677(3) Å, b = 7.3771(5) Å, c = 
20.8583(14) Å, α = 90°, β = 97.998(4)°, γ = 90°, and V = 894.1(1) Å3.  Axial 
photographs and systematic absences were consistent with the compound having 
crystallized in one of two possible monoclinic space groups, i.e., P21 or P21/m.  The 
observed mean | E2-1| value was 0.948 (versus the expectation values of 0.968 and 0.736 
for centric and noncentric data, respectively).  Nevertheless, the chiral space group P21 
(No. 4) was selected since the compound was indicated to be optically pure. 
The structure was solved by direct methods and refined by full-matrix least-
squares on F2 using SHELXTL.11  The asymmetric unit was found to contain only a single 
molecule of 4-bromobenzoic acid (R)-3-(5-methoxybenzofuran-2-yl)butyl ester.  All of 
the nonhydrogen atoms were refined with anisotropic displacement coefficients.  The 
                                                
(9)  COLLECT.; Nonius BV: Delft, The Netherlands, 1998. 
(10)  Otwinowski, Z.; Minor, W. In Methods in Enzymology; Carter, C. W., Sweet, R. M., Eds.; MacMomolecular 
Crystallography, Part A; Academic Press: New York, 1997; pp 307-326. 
(11)  Sheldrick, G. M. SHELXTL, version 5.04; Siemens Analytical X-ray Instruments, Inc.: Madison, WI, 1996. 
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hydrogen atoms were assigned isotropic displacement coefficients U(H) = 1.2U(C) or 
1.5U(Cmethyl), and their coordinates were allowed to ride on their respective carbons.  The 
sample was also found to be twinned with the volume fractions of the twin components 
being 0.9774(6) and 0.0226(6).  Convergence of this single molecule model gave wR(F2) 
= 0.1141 for 2296 unique reflections of which 1735 had I > 2σ(I), 227 parameters and 
199 restraints.  This model, however, gave atoms exhibiting large thermal vibrations, and 
was therefore abandoned in favor of a two-site whole molecule disorder model.  Initial 
occupancy refinement tests yielded site occupancy factors of 0.45(4) and 0.55(4) for the 
atoms of the two sites indicating that each site was half-occupied within the errors of the 
experiment.  A whole molecule disorder model consisting of two exactly half-occupied 
molecules was therefore selected.  Distance, similarity and common plane restraints were 
employed due to the close proximity of the two half molecules.  The weighting scheme 
employed was w = 1/[σ2(Fo2) + 0.1541P] where P = (Fo2 + 2Fc2)/3. The refinement 
converged to R(F) = 0.0483, wR(F2) = 0.0910, and S = 1.224 for 1735 reflections with I > 
2σ(I), and R(F) = 0.0741, wR(F2) = 0.1017, and S = 1.142 for 2296 unique reflections, 
451 parameters and 724 restraints.  The maximum |Δ/σ| in the final cycle of least-squares 
was 0.001, and the residual peaks on the final difference-Fourier map ranged from -0.256 
to 0.354 eÅ-3.  The R-factor ratio between the wR(F2) values for the single molecule 
model and the whole molecule disorder model is R = 0.1141 / 0.1017 = 1.12 while 
R224,2069,0.005 = 1.07, i.e., R > R224,2069,0.005.12  Hence, the notion that the model without whole 
molecule disorder might be preferable is convincingly rejected at the 0.005 level.  
Scattering factors were taken from the International Tables for Crystallography, Volume 
C.13 
The Flack parameter refined to 0.04(2) [vs the expectation values of 0 for the 
correct hand and 1 for the wrong hand] indicating that the coordinates below are for the 
correct hand of the molecule and that the absolute configuration at the chiral carbon is 
unequivocally R (IUPAC Numbering: Wanted = (3R), Found = (3R);  Crystallographic 
                                                
(12)  Hamilton, W. C. Acta Crystallogr. 1965, 18, 502. 
(13)  Maslen, E. N.; Fox, A. G.; O’Keefe, M. A. International Tables for Crystallography: Mathematical, Physical and 
Chemical Tables; Wilson, A. J. C., Ed.; Kluwer: Dordrecht, The Netherlands, 1992; Vol. C, pp 476-516. 
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Atom Numbering: Wanted = (10R / 10'R), Found = (10R / 10'R)).14  Due to the 
complexity of the molecule, the IUPAC butyl C-3 atom is given the crystallographic label 
C10 in the atoms list below.  (The C10' atom listed below corresponds to the chiral atom 
in the second molecule of the two-site whole molecule disorder model employed.)  
For comparison, a refinement of the inverted molecule having the wrong absolute 
structure, i.e., (3S), gave R(F) = 0.0696, wR(F2) = 0.1670, and S = 1.129 for 1735 
reflections with I > 2σ(I), and R(F) = 0.0949, wR(F2) = 0.1858, and S = 1.052 for 2296 
unique reflections, 451 parameters, and 724 restraints for the whole molecule disorder 
model. The Flack parameter based on the wrong absolute structure was 0.95(3).  Based 
on these wR(F2) and Flack values, the (3S) isomer is soundly rejected.  
 
 
 
Table 1.  Crystal data 
 
C20H19BrO4 Z = 2 
Mr = 403.26 Dx = 1.498 Mg m-3 
Monoclinic, P21 (No. 4) Mo Kα radiation 
a = 5.8677 (3) Å Cell parameters from 7927 reflections 
b = 7.3771 (5) Å θ = 1.97–22.46° 
c = 20.8583 (14) Å µ = 2.32 mm-1 
β = 97.998 (4)° T = 200 (2) K 
V = 894.1 (1) Å3 Plate, Colorless 
 
 
 
Table 2.  Data collection 
 
Nonius KappaCCD diffractomer 1735 reflections with I > 2σ(I) 
ω scans; 1440 0.5° rotations Rint = 0.066 
Absorption correction: none θmax = 22.46° 
 h = -6 → 6 
7927 measured reflections k = -7 → 7 
2296 independent reflections l = -22 → 22 
 
 
                                                
(14)  Flack, H. D. Acta Crystallogr. Sect. A 1983, 39, 876. 
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Table 3.  Refinement 
 
Refinement on F2 H atoms constrained to parent site 
R[F2 > 2σ(F2)] = 0.0483  (obs data) 2296 unique reflections  
wR(F2) = 0.0910  (obs data) 451 parameters 
S = 1.224  (obs data) 724 restraints 
R[F2 > 2σ(F2)] = 0.0741  (uniq data) |Δ/σ|max = 0.001 
wR(F2) = 0.1017  (uniq data) Δρmax = 0.354 e Å-1 
S = 1.142  (uniq data) Δρmin = -0.256 e Å-1 
Flack parameter: 0.038 (15) Extinction correction: none 
Absolute structure:14 Calculated weights w = 1/[σ2(Fo2) + 
0.1541P] where P = (Fo2 + 2Fc2)/3 
 
 
 
Table 4.  Atomic site parameters for dwcm003f 
 
 x y z U 
Br1 -0.1992 (9) 0.8493 0.0767 (3) 0.0563 (13) 
O1 0.5174 (14) 0.2757 (12) 0.3126 (5) 0.039 (2) 
C2 0.7373 (17) 0.3442 (11) 0.3350 (5) 0.043 (3) 
C3 0.8475 (15) 0.3863 (12) 0.2851 (5) 0.041 (3) 
H3 0.9986 0.4350 0.2882 0.049 
C3A 0.7002 (15) 0.3461 (10) 0.2259 (5) 0.032 (3) 
C4 0.7143 (17) 0.3591 (12) 0.1597 (5) 0.033 (3) 
H4 0.8492 0.4047 0.1449 0.039 
C5 0.5301 (18) 0.3048 (12) 0.1170 (5) 0.039 (3) 
C6 0.3296 (17) 0.2371 (13) 0.1375 (5) 0.033 (3) 
H6 0.2042 0.2003 0.1064 0.039 
C7 0.3131 (16) 0.2233 (14) 0.2031 (6) 0.035 (3) 
H7 0.1780 0.1776 0.2178 0.042 
C7A 0.4998 (15) 0.2785 (11) 0.2463 (5) 0.034 (2) 
O8 0.5136 (20) 0.3079 (14) 0.0504 (5) 0.041 (3) 
C9 0.7208 (24) 0.3394 (23) 0.0232 (6) 0.049 (4) 
H9A 0.6869 0.3385 -0.0241 0.074 
H9B 0.8326 0.2439 0.0375 0.074 
H9C 0.7850 0.4575 0.0378 0.074 
C10 0.7945 (20) 0.3537 (14) 0.4060 (5) 0.043 (3) 
H10 0.9547 0.4025 0.4156 0.051 
C11 0.7942 (32) 0.1714 (18) 0.4365 (6) 0.050 (4) 
H11A 0.8329 0.1834 0.4836 0.075 
H11B 0.9083 0.0940 0.4199 0.075 
H11C 0.6412 0.1169 0.4263 0.075 
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C12 0.6356 (26) 0.4817 (19) 0.4395 (6) 0.046 (4) 
H12A 0.4738 0.4422 0.4279 0.055 
H12B 0.6757 0.4709 0.4870 0.055 
C13 0.6563 (22) 0.6770 (18) 0.4202 (6) 0.041 (4) 
H13A 0.5965 0.7557 0.4526 0.049 
H13B 0.8206 0.7072 0.4200 0.049 
O14 0.5282 (18) 0.7132 (15) 0.3560 (5) 0.046 (3) 
C15 0.3100 (19) 0.7738 (12) 0.3535 (5) 0.041 (3) 
O16 0.2201 (23) 0.8108 (20) 0.4005 (5) 0.054 (4) 
C17 0.1954 (17) 0.7883 (11) 0.2855 (5) 0.032 (3) 
C18 -0.0240 (18) 0.8709 (13) 0.2751 (5) 0.040 (3) 
H18 -0.0920 0.9144 0.3109 0.048 
C19 -0.1399 (16) 0.8885 (11) 0.2130 (5) 0.039 (3) 
H19 -0.2874 0.9440 0.2059 0.047 
C20 -0.0392 (15) 0.8246 (7) 0.1614 (4) 0.041 (3) 
C21 0.1767 (15) 0.7427 (11) 0.1705 (5) 0.033 (3) 
H21 0.2436 0.6994 0.1345 0.040 
C22 0.2923 (17) 0.7252 (13) 0.2325 (5) 0.038 (3) 
H22 0.4397 0.6695 0.2391 0.045 
Br1' -0.1809 (10) 0.9272 (11) 0.0755 (3) 0.0726 (15) 
O1' 0.5261 (14) 0.3606 (12) 0.3134 (5) 0.042 (3) 
C2' 0.7441 (16) 0.4309 (11) 0.3363 (5) 0.041 (3) 
C3' 0.8558 (15) 0.4738 (13) 0.2866 (5) 0.040 (4) 
H3' 1.0062 0.5237 0.2900 0.048 
C3A' 0.7102 (14) 0.4318 (10) 0.2272 (5) 0.039 (3) 
C4' 0.7269 (15) 0.4447 (13) 0.1611 (5) 0.033 (4) 
H4' 0.8618 0.4914 0.1467 0.039 
C5' 0.5443 (17) 0.3885 (12) 0.1181 (5) 0.046 (3) 
C6' 0.3443 (17) 0.3195 (14) 0.1379 (5) 0.041 (5) 
H6' 0.2205 0.2816 0.1066 0.049 
C7' 0.3253 (17) 0.3058 (14) 0.2037 (6) 0.040 (3) 
H7' 0.1902 0.2590 0.2180 0.047 
C7A' 0.5104 (15) 0.3628 (11) 0.2471 (5) 0.039 (3) 
O8' 0.5322 (19) 0.3919 (15) 0.0515 (5) 0.049 (3) 
C9' 0.7420 (24) 0.4290 (24) 0.0260 (6) 0.046 (4) 
H9A' 0.7126 0.4279 -0.0214 0.069 
H9B' 0.8564 0.3361 0.0410 0.069 
H9C' 0.8004 0.5484 0.0410 0.069 
C10' 0.8007 (20) 0.4419 (14) 0.4073 (5) 0.046 (3) 
H10' 0.9612 0.4898 0.4170 0.055 
C11' 0.7986 (37) 0.2589 (20) 0.4377 (7) 0.074 (6) 
H11D 0.8368 0.2703 0.4848 0.111 
H11E 0.9125 0.1811 0.4210 0.111 
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H11F 0.6453 0.2051 0.4272 0.111 
C12' 0.6431 (24) 0.5697 (19) 0.4409 (6) 0.047 (4) 
H12C 0.4815 0.5293 0.4299 0.056 
H12D 0.6849 0.5593 0.4884 0.056 
C13' 0.6596 (23) 0.7647 (20) 0.4219 (6) 0.050 (4) 
H13C 0.5968 0.8420 0.4540 0.060 
H13D 0.8234 0.7973 0.4222 0.060 
O14' 0.5337 (19) 0.8008 (14) 0.3575 (5) 0.049 (3) 
C15' 0.3155 (19) 0.8615 (12) 0.3539 (5) 0.050 (3) 
O16' 0.2219 (24) 0.9006 (19) 0.4000 (5) 0.074 (5) 
C17' 0.2047 (18) 0.8735 (11) 0.2853 (5) 0.037 (3) 
C18' -0.0179 (17) 0.9502 (15) 0.2740 (5) 0.041 (3) 
H18' -0.0900 0.9912 0.3093 0.050 
C19' -0.1310 (16) 0.9655 (15) 0.2116 (4) 0.044 (3) 
H19' -0.2807 1.0169 0.2038 0.052 
C20' -0.0239 (15) 0.9052 (11) 0.1605 (5) 0.043 (3) 
C21' 0.1951 (16) 0.8294 (13) 0.1707 (5) 0.041 (3) 
H21' 0.2662 0.7886 0.1351 0.050 
C22' 0.3081 (16) 0.8140 (13) 0.2331 (5) 0.035 (3) 
H22' 0.4578 0.7624 0.2403 0.042 
 
 
 
Table 5.  Anisotropic atomic displacement parameters for dwcm003f 
 
 U11 U22 U33 U12 U13 U23 
Br1 0.0435 (14) 0.087 (4) 0.035 (2) 0.000 (2) -0.0086 (12) 0.006 (2) 
O1 0.038 (4) 0.047 (6) 0.032 (4) -0.016 (4) 0.002 (3) -0.013 (5) 
C2 0.038 (5) 0.053 (8) 0.035 (4) -0.007 (6) -0.008 (4) -0.009 (6) 
C3 0.030 (4) 0.057 (9) 0.033 (4) -0.008 (6) -0.003 (4) -0.015 (8) 
C3A 0.028 (4) 0.034 (6) 0.032 (4) -0.016 (5) -0.001 (4) -0.007 (5) 
C4 0.032 (5) 0.038 (9) 0.026 (5) -0.015 (7) -0.003 (4) -0.005 (7) 
C5 0.034 (5) 0.050 (8) 0.031 (5) -0.016 (5) -0.008 (4) 0.000 (5) 
C6 0.026 (5) 0.033 (10) 0.036 (5) -0.007 (5) -0.003 (4) -0.008 (6) 
C7 0.029 (4) 0.038 (7) 0.037 (4) -0.011 (4) 0.003 (4) -0.006 (5) 
C7A 0.033 (4) 0.038 (6) 0.032 (4) -0.012 (4) 0.004 (3) -0.012 (5) 
O8 0.036 (4) 0.054 (7) 0.029 (4) -0.018 (5) -0.010 (4) -0.003 (5) 
C9 0.042 (6) 0.072 (11) 0.028 (6) -0.024 (7) -0.014 (5) 0.000 (7) 
C10 0.041 (5) 0.051 (8) 0.034 (5) 0.000 (7) -0.002 (4) 0.008 (7) 
C11 0.084 (9) 0.032 (9) 0.033 (7) -0.026 (9) 0.002 (7) -0.010 (7) 
C12 0.047 (6) 0.059 (9) 0.026 (5) 0.003 (6) -0.014 (5) -0.003 (6) 
C13 0.043 (5) 0.052 (9) 0.024 (6) -0.003 (7) -0.008 (5) -0.006 (7) 
O14 0.036 (4) 0.066 (8) 0.033 (4) 0.004 (5) -0.002 (3) 0.008 (5) 
J. Am. Chem. Soc. Supporting Information                                   S 24 
   
    
C15 0.036 (5) 0.049 (8) 0.039 (5) -0.005 (6) 0.004 (4) 0.010 (6) 
O16 0.043 (6) 0.087 (11) 0.031 (5) 0.012 (6) 0.005 (5) 0.007 (6) 
C17 0.025 (4) 0.037 (8) 0.033 (4) -0.017 (5) 0.002 (4) 0.001 (5) 
C18 0.033 (4) 0.044 (8) 0.043 (5) -0.009 (6) 0.006 (4) 0.004 (7) 
C19 0.025 (4) 0.044 (8) 0.047 (4) -0.008 (6) 0.000 (4) 0.003 (6) 
C20 0.035 (5) 0.051 (8) 0.034 (5) -0.012 (5) 0.001 (4) 0.015 (6) 
C21 0.032 (4) 0.040 (8) 0.030 (4) -0.007 (5) 0.011 (4) 0.011 (6) 
C22 0.030 (5) 0.047 (8) 0.035 (5) -0.010 (5) 0.004 (4) 0.008 (6) 
Br1' 0.053 (2) 0.122 (4) 0.040 (2) -0.006 (2) -0.0018 (13) -0.001 (3) 
O1' 0.034 (3) 0.070 (7) 0.025 (3) -0.012 (5) 0.010 (3) -0.014 (6) 
C2' 0.031 (5) 0.060 (9) 0.031 (4) -0.006 (6) 0.004 (4) -0.014 (6) 
C3' 0.033 (5) 0.061 (10) 0.027 (5) -0.006 (6) 0.005 (4) -0.017 (6) 
C3A' 0.027 (4) 0.062 (8) 0.028 (4) -0.016 (5) 0.008 (4) -0.011 (6) 
C4' 0.015 (5) 0.056 (11) 0.028 (5) -0.006 (6) 0.006 (4) -0.006 (7) 
C5' 0.028 (5) 0.083 (9) 0.030 (4) -0.020 (6) 0.012 (4) -0.006 (7) 
C6' 0.024 (5) 0.062 (14) 0.035 (5) -0.011 (6) -0.004 (4) -0.011 (6) 
C7' 0.031 (4) 0.060 (8) 0.031 (4) -0.014 (5) 0.015 (4) -0.013 (5) 
C7A' 0.030 (3) 0.065 (7) 0.025 (3) -0.014 (5) 0.012 (3) -0.011 (5) 
O8' 0.031 (4) 0.085 (9) 0.031 (4) -0.024 (6) 0.007 (3) -0.004 (6) 
C9' 0.045 (6) 0.065 (10) 0.030 (6) -0.028 (7) 0.016 (5) -0.002 (7) 
C10' 0.041 (5) 0.066 (9) 0.030 (5) 0.005 (6) 0.004 (4) -0.005 (6) 
C11' 0.120 (12) 0.060 (11) 0.041 (8) 0.000 (13) 0.007 (10) -0.016 (8) 
C12' 0.040 (6) 0.075 (10) 0.029 (6) 0.001 (8) 0.014 (5) -0.003 (6) 
C13' 0.043 (5) 0.078 (9) 0.028 (6) 0.007 (7) 0.003 (4) 0.000 (7) 
O14' 0.038 (4) 0.080 (9) 0.031 (4) 0.005 (5) 0.006 (3) -0.002 (5) 
C15' 0.035 (4) 0.077 (9) 0.038 (4) 0.004 (7) 0.007 (4) 0.001 (7) 
O16' 0.047 (6) 0.137 (15) 0.038 (5) 0.015 (9) 0.012 (5) -0.014 (9) 
C17' 0.028 (4) 0.052 (7) 0.033 (4) -0.015 (6) 0.007 (3) 0.003 (6) 
C18' 0.034 (5) 0.058 (9) 0.035 (5) -0.005 (6) 0.016 (4) 0.005 (6) 
C19' 0.028 (5) 0.055 (8) 0.047 (5) -0.009 (5) 0.002 (4) 0.009 (6) 
C20' 0.041 (5) 0.054 (7) 0.034 (4) -0.006 (6) 0.002 (4) 0.005 (6) 
C21' 0.042 (4) 0.052 (9) 0.031 (4) -0.011 (5) 0.008 (4) 0.009 (6) 
C22' 0.023 (4) 0.046 (9) 0.037 (4) -0.014 (5) 0.007 (4) 0.005 (5) 
 
 
 
Table 6.  Geometric parameters (Å, °) for dwcm003f 
 
Br1—C20 1.890 (7) Br1'—C20' 1.889 (7) 
O1—C7A 1.374 (7) O1'—C7A' 1.374 (7) 
O1—C2 1.404 (7) O1'—C2' 1.401 (7) 
C2—C3 1.337 (8) C2'—C3' 1.340 (8) 
C2—C10 1.473 (8) C2'—C10' 1.474 (8) 
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C3—C3A 1.437 (8) C3'—C3A' 1.437 (8) 
C3A—C7A 1.397 (7) C3A'—C7A' 1.393 (7) 
C3A—C4 1.397 (8) C3A'—C4' 1.398 (7) 
C4—C5 1.362 (8) C4'—C5' 1.363 (8) 
C5—O8 1.379 (7) C5'—O8' 1.380 (7) 
C5—C6 1.399 (8) C5'—C6' 1.394 (8) 
C6—C7 1.390 (8) C6'—C7' 1.395 (8) 
C7—C7A 1.379 (8) C7'—C7A' 1.379 (8) 
O8—C9 1.430 (7) O8'—C9' 1.434 (7) 
C10—C11 1.488 (12) C10'—C11' 1.492 (12) 
C10—C12 1.558 (11) C10'—C12' 1.554 (11) 
C12—C13 1.506 (13) C12'—C13' 1.499 (13) 
C13—O14 1.466 (8) C13'—O14' 1.463 (8) 
O14—C15 1.350 (8) O14'—C15' 1.348 (7) 
C15—O16 1.209 (7) C15'—O16' 1.207 (7) 
C15—C17 1.486 (8) C15'—C17' 1.489 (8) 
C17—C22 1.391 (9) C17'—C22' 1.390 (9) 
C17—C18 1.413 (8) C17'—C18' 1.413 (8) 
C18—C19 1.383 (8) C18'—C19' 1.381 (8) 
C19—C20 1.381 (8) C19'—C20' 1.382 (8) 
C20—C21 1.392 (8) C20'—C21' 1.391 (8) 
C21—C22 1.380 (9) C21'—C22' 1.381 (9) 
 
 
 
C7A—O1—C2 105.5 (5) C7A'—O1'—C2' 105.6 (5) 
C3—C2—O1 110.3 (5) C3'—C2'—O1' 110.2 (5) 
C3—C2—C10 134.8 (7) C3'—C2'—C10' 134.3 (6) 
O1—C2—C10 114.9 (6) O1'—C2'—C10' 115.5 (6) 
C2—C3—C3A 108.8 (5) C2'—C3'—C3A' 108.7 (5) 
C7A—C3A—C4 119.6 (6) C7A'—C3A'—C4' 119.7 (5) 
C7A—C3A—C3 104.1 (5) C7A'—C3A'—C3' 104.3 (5) 
C4—C3A—C3 136.3 (6) C4'—C3A'—C3' 136.0 (6) 
C5—C4—C3A 118.4 (6) C5'—C4'—C3A' 118.1 (6) 
C4—C5—O8 126.3 (6) C4'—C5'—O8' 125.7 (6) 
C4—C5—C6 122.0 (6) C4'—C5'—C6' 122.2 (6) 
O8—C5—C6 111.7 (6) O8'—C5'—C6' 112.2 (6) 
C7—C6—C5 120.3 (6) C5'—C6'—C7' 120.3 (6) 
C7A—C7—C6 117.6 (6) C7A'—C7'—C6' 117.3 (6) 
O1—C7A—C7 126.5 (6) O1'—C7A'—C7' 126.4 (6) 
O1—C7A—C3A 111.3 (5) O1'—C7A'—C3A' 111.3 (5) 
C7—C7A—C3A 122.2 (6) C7'—C7A'—C3A' 122.3 (6) 
C5—O8—C9 117.2 (6) C5'—O8'—C9' 116.7 (6) 
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C2—C10—C11 111.9 (6) C2'—C10'—C11' 111.3 (7) 
C2—C10—C12 114.3 (6) C2'—C10'—C12' 114.9 (6) 
C11—C10—C12 108.6 (8) C11'—C10'—C12' 108.5 (8) 
C13—C12—C10 112.7 (8) C13'—C12'—C10' 113.5 (8) 
O14—C13—C12 111.6 (8) O14'—C13'—C12' 112.0 (9) 
C15—O14—C13 117.3 (7) C15'—O14'—C13' 117.8 (7) 
O16—C15—O14 124.2 (7) O16'—C15'—O14' 124.6 (7) 
O16—C15—C17 124.6 (7) O16'—C15'—C17' 124.4 (7) 
O14—C15—C17 111.2 (6) O14'—C15'—C17' 111.0 (6) 
C22—C17—C18 119.1 (6) C22'—C17'—C18' 119.3 (6) 
C22—C17—C15 123.5 (6) C22'—C17'—C15' 123.7 (6) 
C18—C17—C15 117.4 (6) C18'—C17'—C15' 117.1 (6) 
C19—C18—C17 120.2 (6) C19'—C18'—C17' 120.2 (6) 
C20—C19—C18 119.4 (6) C18'—C19'—C20' 119.3 (6) 
C19—C20—C21 121.4 (6) C19'—C20'—C21' 121.5 (6) 
C19—C20—Br1 119.0 (5) C19'—C20'—Br1' 118.7 (5) 
C21—C20—Br1 119.6 (6) C21'—C20'—Br1' 119.8 (6) 
C22—C21—C20 119.2 (6) C22'—C21'—C20' 119.3 (7) 
C21—C22—C17 120.7 (6) C21'—C22'—C17' 120.6 (6) 
 
 
 
Computer programs 
 
Data collection: COLLECT.8  Cell refinement: DENZO-SMN.9  Data reduction: 
DENZO-SMN.9  Program(s) used to solve structure: Siemens SHELXTL.10  Program(s) 
used to refine structure: Siemens SHELXTL.10  Molecular graphics: Siemens 
SHELXTL.10  Software used to prepare material for publication: Siemens SHELXTL,10 
publCIF,15 printCIF for Word.16 
 
 
 
 
 
 
 
 
 
                                                
(15)  Westrip, S. P. publCIF, version 1.0c; International Union of Crystallography, Abbey Square: Chester, U. K., 
2006.  
(16)  prinfCIF for word; International Union of Crystallography, Abbey Square: Chester, U. K., 2005. 
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